NO860463L - Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensive egenskaper. - Google Patents
Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensive egenskaper.Info
- Publication number
- NO860463L NO860463L NO860463A NO860463A NO860463L NO 860463 L NO860463 L NO 860463L NO 860463 A NO860463 A NO 860463A NO 860463 A NO860463 A NO 860463A NO 860463 L NO860463 L NO 860463L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- formula
- alkyl
- phenylene
- given above
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858503429A GB8503429D0 (en) | 1985-02-11 | 1985-02-11 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO860463L true NO860463L (no) | 1986-08-12 |
Family
ID=10574274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO860463A NO860463L (no) | 1985-02-11 | 1986-02-10 | Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensive egenskaper. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0194048A1 (da) |
| JP (1) | JPS61243063A (da) |
| AU (1) | AU5326286A (da) |
| DK (1) | DK65786A (da) |
| ES (1) | ES8802027A1 (da) |
| FI (1) | FI860619A7 (da) |
| GB (1) | GB8503429D0 (da) |
| GR (1) | GR860367B (da) |
| HU (1) | HUT40414A (da) |
| IL (1) | IL77802A0 (da) |
| NO (1) | NO860463L (da) |
| PT (1) | PT82009B (da) |
| ZA (1) | ZA86852B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9117340D0 (en) * | 1991-08-10 | 1991-09-25 | Fujisawa Pharmaceutical Co | Dihydropyridine compounds,and process for their preparation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2228363A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB1409865A (en) * | 1973-02-13 | 1975-10-15 | Science Union & Cie | Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them |
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| DE2753946A1 (de) * | 1977-12-03 | 1979-06-13 | Bayer Ag | 1-n-aryl-1,4-dihydropyridine und ihre verwendung als arzneimittel |
-
1985
- 1985-02-11 GB GB858503429A patent/GB8503429D0/en active Pending
-
1986
- 1986-02-05 ZA ZA86852A patent/ZA86852B/xx unknown
- 1986-02-05 IL IL77802A patent/IL77802A0/xx unknown
- 1986-02-06 AU AU53262/86A patent/AU5326286A/en not_active Abandoned
- 1986-02-07 GR GR860367A patent/GR860367B/el unknown
- 1986-02-10 HU HU86534A patent/HUT40414A/hu unknown
- 1986-02-10 EP EP86300888A patent/EP0194048A1/en not_active Withdrawn
- 1986-02-10 PT PT82009A patent/PT82009B/pt unknown
- 1986-02-10 NO NO860463A patent/NO860463L/no unknown
- 1986-02-11 DK DK65786A patent/DK65786A/da not_active Application Discontinuation
- 1986-02-11 FI FI860619A patent/FI860619A7/fi not_active Application Discontinuation
- 1986-02-11 ES ES551848A patent/ES8802027A1/es not_active Expired
- 1986-02-12 JP JP61028756A patent/JPS61243063A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB8503429D0 (en) | 1985-03-13 |
| PT82009B (en) | 1987-12-16 |
| AU5326286A (en) | 1986-08-14 |
| ZA86852B (en) | 1987-07-29 |
| PT82009A (en) | 1986-03-01 |
| ES8802027A1 (es) | 1988-03-16 |
| FI860619A7 (fi) | 1986-08-12 |
| DK65786A (da) | 1986-08-12 |
| EP0194048A1 (en) | 1986-09-10 |
| FI860619A0 (fi) | 1986-02-11 |
| JPS61243063A (ja) | 1986-10-29 |
| ES551848A0 (es) | 1988-03-16 |
| IL77802A0 (en) | 1986-08-31 |
| HUT40414A (en) | 1986-12-28 |
| DK65786D0 (da) | 1986-02-11 |
| GR860367B (en) | 1986-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI91527B (fi) | Foerfarande foer framstaellning av en terapeutiskt anvaendbar (S)-1-(3-dimetylaminopropyl)-1-(4'-fluorfenyl)-1,3-dihydrobensofuran-5-karbonitril | |
| US4892875A (en) | Substituted heterocyclylalkyl esters of 1,4-dihydropyridine-3,5-dicarboxylic acids | |
| US4430333A (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
| US4707486A (en) | Diaryl piperidine containing esters of 1,4-dihydropyridines and coronary therapeutic use | |
| CS228506B2 (en) | Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid | |
| JPH0272171A (ja) | 新規なベンゾピラン誘導体およびその製法 | |
| KR920005742B1 (ko) | 약제학상 유용한 디하이드로피리디닐디카르복실레이트 아마이드 및 에스테르의 제조방법 | |
| Alajarin et al. | Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine | |
| NO860471L (no) | Fremgangsmaate for fremstilling av nye heterocykliske derivater. | |
| EP0197488A2 (en) | 1,4-Dihydropyiridine derivative, a process for preparing the same, a pharmaceutical composition as well as the use thereof | |
| JPS61257983A (ja) | １，４−ジヒドロピリジン及びこれを有効成分とする医薬組成物 | |
| US5017586A (en) | 5-dialkylaminomethyl-2-furanomethanol derivatives having anti-hypertensive properties | |
| NO860464L (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive dihydropyridinderivater. | |
| NO860462L (no) | Fremgangsmaate for fremstilling av et dihydropyridin. | |
| NO860463L (no) | Fremgangsmaate for fremstilling av dihydropyridinderivater med antihypertensive egenskaper. | |
| EP0194751B1 (en) | Dihydropyridine alkanol amines, process for their preparation and pharmaceutical compositions containing them | |
| JPS62281860A (ja) | アルキレンアミノアルキレン ヘテロ原子基を有するジヒドロ−３，５−ジカルボキシレ−ト | |
| NO860461L (no) | Fremgangsmaate for fremstilling av dihydropyridin-derivater | |
| NO167029B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater | |
| JPH0314020B2 (da) | ||
| WO1986002640A1 (en) | Dihydropyridin-3,5-dicarboxylates incorporating aryloxypropanolamine moieties | |
| RU2155751C2 (ru) | Производные 1,4-дигидропиридина, смесь их изомеров или отдельные изомеры, фармацевтическая композиция на их основе и 2-хлор-3-цианобензальдегид | |
| EP0314038A1 (de) | Neue Pyrrolidine | |
| JPH01156959A (ja) | 抗腫瘍効果増強剤 | |
| EP0741705A1 (en) | 4-(2-(3-aryloxy-2-hydroxypropylamino alkyloxy)-5-nitrophenyl)-1,4-dihydropyridines as antihypertensive agents |